Narcolepsy Type 1
30
11
11
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
17%
5 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (30)
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
Decreasing Nightmares in Adults With Narcolepsy
Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)
A Study of TAK-861 in People With Narcolepsy Type 1
A Study of TAK-861 for the Treatment of Narcolepsy Type 1
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
A Study of TAK-861 in Participants With Narcolepsy Type 1
Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia
Mentalizating in Adults Suffering from Narcolepsy Type 1.
Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1